Biweekly cisplatin (C) and gemcitabine (G) in patients (pts) with advanced biliary tract cancer (ABTC): A retrospective analysis.

Authors

null

Daniel H. Ahn

The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Richard J. Solove Research Institute, Columbus, OH

Josh Reardon , Chul Ahn , Manojkumar Bupathi , Kristen Keon Ciombor , Christina Sing-Ying Wu , Tanios S. Bekaii-Saab , Daniel H. Ahn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 434)

DOI

10.1200/JCO.2017.35.4_suppl.434

Abstract #

434

Poster Bd #

K18

Abstract Disclosures

Similar Posters

Poster

2018 Gastrointestinal Cancers Symposium

Second-line chemotherapy in patients with advanced biliary tract cancer.

Second-line chemotherapy in patients with advanced biliary tract cancer.

First Author: Naminatsu Takahara